Global Vaccines Market – Industry Trends and Forecast to 2028

  • Pharmaceutical
  • Published Report
  • Feb 2021
  • Global
  • 350 Pages
  • No of Tables: 935
  • No of Figures: 88

Global Vaccines Market, By Composition (Combination Vaccines, Monovaccines), Type (Subunit, Recombinant, Polysaccharide & Conjugate Vaccines, Live-Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, DNA Vaccines), Kind (Routine Vaccine, Recommended Vaccine, Required Vaccine), Age of Administration (Pediatric Vaccine, Adult Vaccine), Diseases (Pneumococcal Disease, Measles, Mumps & Varicella, DPT, Hepatitis, Influenza, Typhoid, Meningococcal, Rabies, Japanese Encephalitis, Yellow Fever, Others), Route of Administration (Injectable, Oral, Nasal), End User (Community Hospitals, Hospitals, Specialty Centres, Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy), Country (U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, Rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2028

Vaccines Market Market Analysis and Insights: Global Vaccines Market

The vaccines market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the market is growing with a CAGR of 6.9% in the forecast period of 2021 to 2028 and is expected to reach USD 61,988.47 million by 2028. Growing immunization programs and campaigns and high prevalence of chronic conditions such as flu and bacterial infectious diseases are the major drivers which has propelled the demand of the vaccines market in the forecast period.

Vaccines are the product that has the capability to reduce the risk of getting a disease by working with the body’s own immune system in order to build up the protection against the deadly pathogens. Various kinds of vaccines have discovered for life threatening diseases which are preventing around 2-3 million deaths every year caused due to diseases such as tetanus, diphtheria, pertussis, measles and influenza among others.

New and novel vaccine launch earns the patients beliefs and provides market with a new future that can have a positive effect on the vaccines market growth. Moreover, new vaccine launch is also depicting that market players are constantly engaged in the vaccines market growth. This thus signifies that introduction of innovative products acts as driver for the vaccines market growth. The regulation processes and document formation of the manufacturing companies in different countries can hamper the growth of the vaccines market. The market players operating in vaccines market are adopting several strategic initiatives expected to provide opportunity for their business in various dimensions and leading the vaccines market growth. The fear among patients related to injections and needle sticks acts as challenge for the vaccines market growth.

The vaccines market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the vaccines market scenario contact Data Bridge Market Research for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.

Vaccines Market Vaccines Market Scope and Market Size

The vaccines market is segmented on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel. The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.

  • On the basis of composition, the vaccines market is segmented into combination vaccines, monovaccines. In 2021, combination vaccines segment is dominating the market because combination vaccines are effective against multiple diseases by administration of a single shot.
  • On the basis of type, the vaccines market is segmented into subunit, recombinant, polysaccharide and conjugate vaccines, live-attenuated vaccines, inactivated vaccines, toxoid vaccines and DNA vaccines. In 2021, subunit, recombinant, polysaccharide and conjugate vaccine segment is dominating the market because these vaccines have been reported to induce strong immune response on almost everyone who needs them including people with weakened immune systems and long-term health problems.
  • On the basis of kind, the vaccines market is segmented into routine vaccine, recommended vaccine and required vaccine. In 2021, routine vaccine segment is dominating the market because these are mostly used for childhood vaccination and government is putting major emphasis on childhood vaccination all over the world.
  • On the basis of age of administration, the vaccines market is segmented into pediatric vaccine and adult vaccine. In 2021, pediatric vaccine segment is dominating the market because children are more prone to infectious disease among other due to developing immune system and hence needs proper vaccination.
  • On the basis of diseases, the vaccines market is segmented into pneumococcal disease, measles, mumps & varicella, DPT, hepatitis, influenza, typhoid, meningococcal, rabies, Japanese encephalitis, yellow fever and others. In 2021, pneumococcal disease segment is dominating the market because of rising prevalence on pneumonia infection and increasing immunization campaign launch for the betterment of the population.
  • On the basis of route of administration, the vaccines market is segmented into injectable, oral and nasal. In 2021, injectable segment is dominating the market because most of the vaccines are administered via parenteral route and induces strong systemic response when injected via same route.
  • On the basis of end user, the vaccines market is segmented into community hospitals, hospitals, specialty centres, clinics and others. In 2021, community hospitals segment is dominating the market because most of the vaccination and immunization is carried out by regulatory bodies and concerned authorities.
  • On the basis of distribution channel, the vaccines market is segmented into hospital pharmacy, retail pharmacy and online pharmacy. In 2021, hospital pharmacy segment is dominating the market because vaccines are directly procured from the company distributors.

Vaccines Market Global Vaccines Market Country Level Analysis

Global vaccines market is analyzed and market size information is provided on the basis of composition, type, kind, age of administration, diseases, route of administration, end user and distribution channel as referenced above.

The countries covered in the global vaccines market report are the U.S., Canada, Mexico, Germany, U.K., France, Italy, Spain, Netherlands, Russia, Switzerland, Turkey, Austria, Norway, Hungary, Lithuania, Ireland, Poland, rest of Europe, Japan, China, Australia, India, South Korea, Singapore, Indonesia, Thailand, Malaysia, Philippines, Vietnam, rest of Asia-Pacific, Brazil, Argentina, Peru, rest of South America, Saudi Arabia, South Africa, UAE, Israel, Kuwait, Egypt and rest of Middle East and Africa.

Combination vaccines segment in North America region is expected to grow with the highest growth rate in the forecast period of 2021 to 2028 because vaccines are effective against multiple diseases by administration of a single shot. The U.S. is leading the growth of the North America vaccines market and combination vaccines segment is dominating in the country due to rise in prevalence of government investment for the combination vaccination. Germany is leading the growth of Europe region and combination vaccine segment is dominating the vaccines market because of rising prevalence of multiple flu related diseases and infection. Japan is leading the growth of Asia-Pacific region because of rising research and development for the advanced vaccination program.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.

High Prevalence of Chronic Condition such as Flu and Bacterial Infectious Diseases is boosting the Vaccines Market Growth

The vaccines market also provides you with detailed market analysis for every country growth in vaccines industry with vaccines drugs sales, impact of advancement in the vaccines technology and changes in regulatory scenarios with their support for the vaccines market. The data is available for historic period 2010 to 2019.

Competitive Landscape and Vaccines Market Share Analysis

The vaccines market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to vaccines market.

The major companies which are dealing in the global vaccines market report are Bharat Biotech, Biological E Limited, Bio Farma, Emergent BioSolutions Inc., Dynavax Technologies, Valneva SE, Bavarian Nordic, Altimmune, Merck Sharp & Dohme Corp. (a subsidiary of Merck & Co., Inc.), Takeda Pharmaceutical Company Limited, Seqirus (a subsidiary of CSL Limited), Abbott, AstraZeneca, Sanofi, Pfizer Inc., Janssen Global Services, LLC (a subsidiary of Johnson & Johnson Services, Inc.), F. Hoffmann-La Roche Ltd, DAIICHI SANKYO COMPANY, LIMITED, ALK, Panacea Biotec Ltd, BAXTER VACCINES (a subsidiary of Baxter), GlaxoSmithKline plc, Lanzhou Biological Products Research Institute Co., Ltd., Serum Institute of India Pvt. Ltd. among other global and domestic players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.

Many product launches and agreements are also initiated by the companies’ worldwide which are also accelerating the vaccines market.

For instance,

  • In November 2020, GlaxoSmithKline plc along with Medicines for Malaria Venture presented a positive data (TEACH study) of tafenoquine used for the treatment of Plasmodium vivax malaria in children and adolescents. During the four months of examination, 95% of studied 60 subjects that did not show the signs of Plasmodium vivax malaria. The results were presented through virtual annual meeting of American Society of Tropical Medicine & hygiene 2020. This has helped the company to move forward on the product for the treatment of malaria and to provide the evidence of their product.

Collaboration, product launch, business expansion, award and recognition, joint ventures and other strategies by the market player is enhancing the company market in the Vaccines market which also provides the benefit for organization to improve their offering for Vaccines.

Customization Available: Global Vaccines Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

LIST OF TABLES 

TABLE 1 GLOBAL VACCINES MARKET, PIPELINE ANALYSIS

TABLE 2 REGULATIONS IMPOSED BY SEVERAL REGULATORY AGENCIES IN DIFFERENT REGIONS

TABLE 3 RECOMMENDED TEMPERATURE AND STORAGE LENGTH AT VARIOUS LEVEL OF THE COLD CHAIN.

TABLE 4 PROCEDURES FOR REPORTING TO UNICEF VACCINE ARRIVALS.

TABLE 5 LOGISITCS PROCESS ACORSS DIFFERENT REGIONS.

TABLE 6 THE U.S. FUNDING FOR GAVI (2015-2019)

TABLE 7 PRICE OF THE VACCINES BETWEEN THE U.S. AND DEVELOPING COUNTRIES

TABLE 8 VACCINES UNDER CLINICAL TRIAL

TABLE 9 THE SIDE EFFECTS RELATED TO THE VACCINES

TABLE 10 INCREASE IN OPERATIONAL COST COMPONENTS DUE TO COVID-19

TABLE 11 TOTAL NUMBER OF CASES FOR MEASLES REPORTED BY THE TEN COUNTRIES

TABLE 12 GLOBAL VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 13 GLOBAL COMBINATION VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 14 GLOBAL MONO VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 15 GLOBAL VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 16 GLOBAL SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 17 GLOBAL LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 18 GLOBAL LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 19 GLOBAL INACTIVATED VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 20 GLOBAL INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 21 GLOBAL TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 22 GLOBAL TOXOID VACCINES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 23 GLOBAL VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 24 GLOBAL ROUTINE VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 25 GLOBAL ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 26 GLOBAL RECOMMENDED VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 27 GLOBAL RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 28 GLOBAL REQUIRED VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 29 GLOBAL REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 30 GLOBAL VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 31 GLOBAL PEDIATRIC VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 32 GLOBAL PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 33 GLOBAL ADULT VACCINE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 34 GLOBAL ADULT IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 35 GLOBAL PNEUMOCOCCAL DISEASE IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 36 GLOBAL MEASLES, MUMPS & RUBELLA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 37 GLOBAL DPT IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 38 GLOBAL HEPATITIS IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 39 GLOBAL INFLUENZA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 40 GLOBAL TYPHOID IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 41 GLOBAL MENINGOCOCCAL IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 42 GLOBAL VARICELLA IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 43 GLOBAL RABIES IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 44 GLOBAL JAPANESE ENCEPHALITIS IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 45 GLOBAL YELLOW FEVER IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 46 GLOBAL OTHER IN VACCINES MARKET, BY REGION, 2017-2028 (USD MILLION)

TABLE 47 GLOBAL VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 48 GLOBAL INJECTABLE IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 49 GLOBAL INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 50 GLOBAL ORAL IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 51 GLOBAL NASAL IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 52 GLOBAL VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 53 GLOBAL COMMUNITY HOSPITALS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 54 GLOBAL HOSPITALS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 55 GLOBAL SPECIALTY CENTRES IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 56 GLOBAL CLINICS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 57 GLOBAL OTHERS IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 58 GLOBAL VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 59 GLOBAL HOSPITAL PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 60 GLOBAL RETAIL PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 61 GLOBAL ONLINE PHARMACY IN VACCINES MARKET, BY REGION, 2019-2028 (USD MILLION)

TABLE 62 GLOBAL VACCINES MARKET, BY REGION, 2018-2028 (USD MILLION)

TABLE 63 NORTH AMERICA VACCINES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 64 NORTH AMERICA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 65 NORTH AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 66 NORTH AMERICA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 67 NORTH AMERICA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 68 NORTH AMERICA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 69 NORTH AMERICA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 70 NORTH AMERICA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 71 NORTH AMERICA ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 72 NORTH AMERICA RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 73 NORTH AMERICA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 74 NORTH AMERICA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 75 NORTH AMERICA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 76 NORTH AMERICA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 77 NORTH AMERICA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 78 NORTH AMERICA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 79 NORTH AMERICA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 80 NORTH AMERICA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 81 NORTH AMERICA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 82 U.S. VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 83 U.S. VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 84 U.S. SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 85 U.S. LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 86 U.S. INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 87 U.S. TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 88 U.S. VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 89 U.S. ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 90 U.S. RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 91 U.S. REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 92 U.S. VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 93 U.S. PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 94 U.S. ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 95 U.S. VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 96 U.S. VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 97 U.S. INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 98 U.S. VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 99 U.S. VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 100 CANADA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 101 CANADA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 102 CANADA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 103 CANADA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 104 CANADA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 105 CANADA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 106 CANADA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 107 CANADA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 108 CANADA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 109 CANADA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 110 CANADA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 111 CANADA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 112 CANADA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 113 CANADA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 114 CANADA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 115 CANADA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 116 CANADA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 117 CANADA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 118 MEXICO VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 119 MEXICO VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 120 MEXICO SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 121 MEXICO LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 122 MEXICO INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 123 MEXICO TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 124 MEXICO VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 125 MEXICO ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 126 MEXICO RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 127 MEXICO REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 128 MEXICO VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 129 MEXICO PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 130 MEXICO ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 131 MEXICO VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 132 MEXICO VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 133 MEXICO INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 134 MEXICO VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 135 MEXICO VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 136 EUROPE VACCINES MARKET, BY COUNTRY, 2019-2028 (USD MILLION)

TABLE 137 EUROPE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 138 EUROPE VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 139 EUROPE SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 140 EUROPE LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 141 EUROPE INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 142 EUROPE TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 143 EUROPE VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 144 EUROPE ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 145 EUROPE RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 146 EUROPE REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 147 EUROPE VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 148 EUROPE PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 149 EUROPE ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 150 EUROPE VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 151 EUROPE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 152 EUROPE INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 153 EUROPE VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 154 EUROPE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 155 GERMANY VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 156 GERMANY VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 157 GERMANY SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 158 GERMANY LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 159 GERMANY INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 160 GERMANY TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 161 GERMANY VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 162 GERMANY ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 163 GERMANY RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 164 GERMANY REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 165 GERMANY VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 166 GERMANY PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 167 GERMANY ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 168 GERMANY VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 169 GERMANY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 170 GERMANY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 171 GERMANY VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 172 GERMANY INJECTABLE IN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 173 FRANCE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 174 FRANCE VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 175 FRANCE SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 176 FRANCE LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 177 FRANCE INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 178 FRANCE TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 179 FRANCE VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 180 FRANCE ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 181 FRANCE RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 182 FRANCE REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 183 FRANCE VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 184 FRANCE PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 185 FRANCE ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 186 FRANCE VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 187 FRANCE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 188 FRANCE INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 189 FRANCE VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 190 FRANCE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 191 U.K. VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 192 U.K. VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 193 U.K. SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 194 U.K. LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 195 U.K. INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 196 U.K. TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 197 U.K. VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 198 U.K. ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 199 U.K. RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 200 U.K. REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 201 U.K. VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 202 U.K. PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 203 U.K. ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 204 U.K. VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 205 U.K. VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 206 U.K. INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 207 U.K. VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 208 U.K. VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 209 ITALY VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 210 ITALY VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 211 ITALY SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 212 ITALY LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 213 ITALY INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 214 ITALY TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 215 ITALY VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 216 ITALY ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 217 ITALY RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 218 ITALY REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 219 ITALY VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 220 ITALY PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 221 ITALY ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 222 ITALY VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 223 ITALY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 224 ITALY INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 225 ITALY VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 226 ITALY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 227 SPAIN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 228 SPAIN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 229 SPAIN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 230 SPAIN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 231 SPAIN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 232 SPAIN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 233 SPAIN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 234 SPAIN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 235 SPAIN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 236 SPAIN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 237 SPAIN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 238 SPAIN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 239 SPAIN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 240 SPAIN VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 241 SPAIN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 242 SPAIN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 243 SPAIN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 244 SPAIN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 245 NETHERLAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 246 NETHERLAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 247 NETHERLAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 248 NETHERLAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 249 NETHERLAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 250 NETHERLAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 251 NETHERLAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 252 NETHERLAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 253 NETHERLAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 254 NETHERLAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 255 NETHERLAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 256 NETHERLAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 257 NETHERLAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 258 NETHERLAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 259 NETHERLAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 260 NETHERLAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 261 NETHERLAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 262 NETHERLAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 263 RUSSIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 264 RUSSIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 265 RUSSIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 266 RUSSIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 267 RUSSIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 268 RUSSIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 269 RUSSIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 270 RUSSIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 271 RUSSIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 272 RUSSIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 273 RUSSIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 274 RUSSIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 275 RUSSIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 276 RUSSIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 277 RUSSIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 278 RUSSIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 279 RUSSIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 280 RUSSIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 281 SWITZERLAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 282 SWITZERLAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 283 SWITZERLAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 284 SWITZERLAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 285 SWITZERLAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 286 SWITZERLAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 287 SWITZERLAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 288 SWITZERLAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 289 SWITZERLAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 290 SWITZERLAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 291 SWITZERLAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 292 SWITZERLAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 293 SWITZERLAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 294 SWITZERLAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 295 SWITZERLAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 296 SWITZERLAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 297 SWITZERLAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 298 SWITZERLAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 299 TURKEY VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 300 TURKEY VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 301 TURKEY SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 302 TURKEY LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 303 TURKEY INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 304 TURKEY TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 305 TURKEY VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 306 TURKEY ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 307 TURKEY RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 308 TURKEY REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 309 TURKEY VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 310 TURKEY PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 311 TURKEY ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 312 TURKEY VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 313 TURKEY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 314 TURKEY INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 315 TURKEY VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 316 TURKEY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 317 AUSTRIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 318 AUSTRIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 319 AUSTRIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 320 AUSTRIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 321 AUSTRIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 322 AUSTRIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 323 AUSTRIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 324 AUSTRIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 325 AUSTRIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 326 AUSTRIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 327 AUSTRIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 328 AUSTRIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 329 AUSTRIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 330 AUSTRIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 331 AUSTRIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 332 AUSTRIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 333 AUSTRIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 334 AUSTRIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 335 NORWAY VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 336 NORWAY VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 337 NORWAY SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 338 NORWAY LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 339 NORWAY INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 340 NORWAY TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 341 NORWAY VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 342 NORWAY ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 343 NORWAY RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 344 NORWAY REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 345 NORWAY VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 346 NORWAY PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 347 NORWAY ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 348 NORWAY VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 349 NORWAY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 350 NORWAY INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 351 NORWAY VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 352 NORWAY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 353 HUNGARY VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 354 HUNGARY VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 355 HUNGARY SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 356 HUNGARY LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 357 HUNGARY INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 358 HUNGARY TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 359 HUNGARY VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 360 HUNGARY ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 361 HUNGARY RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 362 HUNGARY REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 363 HUNGARY VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 364 HUNGARY PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 365 HUNGARY ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 366 HUNGARY VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 367 HUNGARY VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 368 HUNGARY INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 369 HUNGARY VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 370 HUNGARY VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 371 LITHUANIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 372 LITHUANIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 373 LITHUANIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 374 LITHUANIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 375 LITHUANIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 376 LITHUANIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 377 LITHUANIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 378 LITHUANIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 379 LITHUANIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 380 LITHUANIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 381 LITHUANIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 382 LITHUANIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 383 LITHUANIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 384 LITHUANIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 385 LITHUANIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 386 LITHUANIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 387 LITHUANIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 388 LITHUANIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 389 IRELAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 390 IRELAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 391 IRELAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 392 IRELAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 393 IRELAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 394 IRELAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 395 IRELAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 396 IRELAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 397 IRELAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 398 IRELAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 399 IRELAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 400 IRELAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 401 IRELAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 402 IRELAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 403 IRELAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 404 IRELAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 405 IRELAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 406 IRELAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 407 POLAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 408 POLAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 409 POLAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 410 POLAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 411 POLAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 412 POLAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 413 POLAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 414 POLAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 415 POLAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 416 POLAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 417 POLAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 418 POLAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 419 POLAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 420 POLAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 421 POLAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 422 POLAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 423 POLAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 424 POLAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 425 REST OF EUROPE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 426 ASIA-PACIFIC VACCINES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 427 ASIA-PACIFIC VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 428 ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 429 ASIA-PACIFIC SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 430 ASIA-PACIFIC LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 431 ASIA-PACIFIC INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 432 ASIA-PACIFIC TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 433 ASIA-PACIFIC VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 434 ASIA-PACIFIC ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 435 ASIA-PACIFIC RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 436 ASIA-PACIFIC REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 437 ASIA-PACIFIC VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 438 ASIA-PACIFIC PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 439 ASIA-PACIFIC ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 440 ASIA-PACIFIC VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 441 ASIA-PACIFIC VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 442 ASIA-PACIFIC INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 443 ASIA-PACIFIC VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 444 ASIA-PACIFIC VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 445 JAPAN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 446 JAPAN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 447 JAPAN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 448 JAPAN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 449 JAPAN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 450 JAPAN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 451 JAPAN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 452 JAPAN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 453 JAPAN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 454 JAPAN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 455 JAPAN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 456 JAPAN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 457 JAPAN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 458 JAPAN VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 459 JAPAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 460 JAPAN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 461 JAPAN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 462 JAPAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 463 CHINAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 464 CHINAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 465 CHINASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 466 CHINALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 467 CHINAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 468 CHINATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 469 CHINAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 470 CHINAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 471 CHINARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 472 CHINAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 473 CHINAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 474 CHINAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 475 CHINAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 476 CHINAVACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 477 CHINAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 478 CHINAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 479 CHINAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 480 CHINA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 481 AUSTRALIAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 482 AUSTRALIAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 483 AUSTRALIASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 484 AUSTRALIALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 485 AUSTRALIAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 486 AUSTRALIATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 487 AUSTRALIAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 488 AUSTRALIAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 489 AUSTRALIARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 490 AUSTRALIAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 491 AUSTRALIAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 492 AUSTRALIAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 493 AUSTRALIAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 494 AUSTRALIAVACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 495 AUSTRALIAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 496 AUSTRALIAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 497 AUSTRALIAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 498 AUSTRALIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 499 INDIAVACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 500 INDIAVACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 501 INDIASUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 502 INDIALIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 503 INDIAINACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 504 INDIATOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 505 INDIAVACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 506 INDIAROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 507 INDIARECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 508 INDIAREQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 509 INDIAVACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 510 INDIAPEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 511 INDIAADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 512 INDIAVACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 513 INDIAVACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 514 INDIAINJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 515 INDIAVACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 516 INDIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 517 SOUTH KOREA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 518 SOUTH KOREA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 519 SOUTH KOREA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 520 SOUTH KOREA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 521 SOUTH KOREA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 522 SOUTH KOREA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 523 SOUTH KOREA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 524 SOUTH KOREA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 525 SOUTH KOREA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 526 SOUTH KOREA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 527 SOUTH KOREA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 528 SOUTH KOREA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 529 SOUTH KOREA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 530 SOUTH KOREA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 531 SOUTH KOREA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 532 SOUTH KOREA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 533 SOUTH KOREA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 534 SOUTH KOREA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 535 SINGAPORE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 536 SINGAPORE VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 537 SINGAPORE SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 538 SINGAPORE LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 539 SINGAPORE INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 540 SINGAPORE TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 541 SINGAPORE VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 542 SINGAPORE ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 543 SINGAPORE RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 544 SINGAPORE REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 545 SINGAPORE VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 546 SINGAPORE PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 547 SINGAPORE ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 548 SINGAPORE VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 549 SINGAPORE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 550 SINGAPORE INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 551 SINGAPORE VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 552 SINGAPORE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 553 MALAYSIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 554 MALAYSIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 555 MALAYSIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 556 MALAYSIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 557 MALAYSIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 558 MALAYSIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 559 MALAYSIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 560 MALAYSIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 561 MALAYSIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 562 MALAYSIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 563 MALAYSIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 564 MALAYSIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 565 MALAYSIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 566 MALAYSIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 567 MALAYSIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 568 MALAYSIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 569 MALAYSIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 570 MALAYSIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 571 THAILAND VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 572 THAILAND VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 573 THAILAND SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 574 THAILAND LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 575 THAILAND INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 576 THAILAND TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 577 THAILAND VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 578 THAILAND ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 579 THAILAND RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 580 THAILAND REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 581 THAILAND VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 582 THAILAND PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 583 THAILAND ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 584 THAILAND VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 585 THAILAND VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 586 THAILAND INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 587 THAILAND VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 588 THAILAND VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 589 INDONESIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 590 INDONESIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 591 INDONESIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 592 INDONESIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 593 INDONESIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 594 INDONESIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 595 INDONESIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 596 INDONESIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 597 INDONESIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 598 INDONESIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 599 INDONESIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 600 INDONESIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 601 INDONESIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 602 INDONESIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 603 INDONESIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 604 INDONESIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 605 INDONESIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 606 INDONESIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 607 PHILIPPINES VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 608 PHILIPPINES VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 609 PHILIPPINES SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 610 PHILIPPINES LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 611 PHILIPPINES INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 612 PHILIPPINES TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 613 PHILIPPINES VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 614 PHILIPPINES ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 615 PHILIPPINES RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 616 PHILIPPINES REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 617 PHILIPPINES VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 618 PHILIPPINES PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 619 PHILIPPINES ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 620 PHILIPPINES VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 621 PHILIPPINES VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 622 PHILIPPINES INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 623 PHILIPPINES VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 624 PHILIPPINES VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 625 VIETNAM VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 626 VIETNAM VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 627 VIETNAM SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 628 VIETNAM LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 629 VIETNAM INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 630 VIETNAM TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 631 VIETNAM VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 632 VIETNAM ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 633 VIETNAM RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 634 VIETNAM REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 635 VIETNAM VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 636 VIETNAM PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 637 VIETNAM ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 638 VIETNAM VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 639 VIETNAM VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 640 VIETNAM INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 641 VIETNAM VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 642 VIETNAM VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 643 REST OF ASIA-PACIFIC VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 644 MIDDLE EAST & AFRICA VACCINES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 645 MIDDLE EAST & AFRICA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 646 MIDDLE EAST & AFRICA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 647 MIDDLE EAST & AFRICA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 648 MIDDLE EAST & AFRICA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 649 MIDDLE EAST & AFRICA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 650 MIDDLE EAST & AFRICA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 651 MIDDLE EAST & AFRICA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 652 MIDDLE EAST & AFRICA ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 653 MIDDLE EAST & AFRICA RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 654 MIDDLE EAST & AFRICA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 655 MIDDLE EAST & AFRICA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 656 MIDDLE EAST & AFRICA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 657 MIDDLE EAST & AFRICA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 658 MIDDLE EAST & AFRICA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 659 MIDDLE EAST & AFRICA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 660 MIDDLE EAST & AFRICA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 661 MIDDLE EAST & AFRICA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 662 MIDDLE EAST & AFRICA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 663 SAUDI ARABIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 664 SAUDI ARABIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 665 SAUDI ARABIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 666 SAUDI ARABIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 667 SAUDI ARABIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 668 SAUDI ARABIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 669 SAUDI ARABIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 670 SAUDI ARABIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 671 SAUDI ARABIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 672 SAUDI ARABIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 673 SAUDI ARABIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 674 SAUDI ARABIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 675 SAUDI ARABIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 676 SAUDI ARABIA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 677 SAUDI ARABIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 678 SAUDI ARABIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 679 SAUDI ARABIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 680 SAUDI ARABIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 681 JORDAN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 682 JORDAN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 683 JORDAN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 684 JORDAN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 685 JORDAN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 686 JORDAN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 687 JORDAN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 688 JORDAN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 689 JORDAN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 690 JORDAN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 691 JORDAN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 692 JORDAN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 693 JORDAN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 694 JORDAN VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 695 JORDAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 696 JORDAN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 697 JORDAN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 698 JORDAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 699 OMAN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 700 OMAN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 701 OMAN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 702 OMAN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 703 OMAN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 704 OMAN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 705 OMAN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 706 OMAN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 707 OMAN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 708 OMAN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 709 OMAN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 710 OMAN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 711 OMAN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 712 OMAN VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 713 OMAN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 714 OMAN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 715 OMAN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 716 OMAN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 717 QATAR VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 718 QATAR VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 719 QATAR SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 720 QATAR LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 721 QATAR INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 722 QATAR TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 723 QATAR VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 724 QATAR ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 725 QATAR RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 726 QATAR REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 727 QATAR VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 728 QATAR PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 729 QATAR ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 730 QATAR VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 731 QATAR VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 732 QATAR INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 733 QATAR VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 734 QATAR VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 735 YEMEN VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 736 YEMEN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 737 YEMEN SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 738 YEMEN LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 739 YEMEN INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 740 YEMEN TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 741 YEMEN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 742 YEMEN ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 743 YEMEN RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 744 YEMEN REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 745 YEMEN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 746 YEMEN PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 747 YEMEN ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 748 YEMEN VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 749 YEMEN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 750 YEMEN INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 751 YEMEN VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 752 YEMEN VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 753 REST OF SAUDI ARABIA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 754 REST OF SAUDI ARABIA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 755 REST OF SAUDI ARABIA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 756 REST OF SAUDI ARABIA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 757 REST OF SAUDI ARABIA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 758 REST OF SAUDI ARABIA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 759 REST OF SAUDI ARABIA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 760 REST OF SAUDI ARABIA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 761 REST OF SAUDI ARABIA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 762 REST OF SAUDI ARABIA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 763 REST OF SAUDI ARABIA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 764 REST OF SAUDI ARABIA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 765 REST OF SAUDI ARABIA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 766 REST OF SAUDI ARABIA VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 767 REST OF SAUDI ARABIA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 768 REST OF SAUDI ARABIA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 769 REST OF SAUDI ARABIA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 770 REST OF SAUDI ARABIA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 771 SOUTH AFRICA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 772 SOUTH AFRICA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 773 SOUTH AFRICA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 774 SOUTH AFRICA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 775 SOUTH AFRICA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 776 SOUTH AFRICA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 777 SOUTH AFRICA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 778 SOUTH AFRICA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 779 SOUTH AFRICA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 780 SOUTH AFRICA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 781 SOUTH AFRICA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 782 SOUTH AFRICA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 783 SOUTH AFRICA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 784 SOUTH AFRICA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 785 SOUTH AFRICA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 786 SOUTH AFRICA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 787 SOUTH AFRICA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 788 SOUTH AFRICA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 789 UAE VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 790 UAE VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 791 UAE SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 792 UAE LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 793 UAE INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 794 UAE TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 795 UAE VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 796 UAE ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 797 UAE RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 798 UAE REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 799 UAE VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 800 UAE PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 801 UAE ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 802 UAE VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 803 UAE VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 804 UAE INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 805 UAE VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 806 UAE VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 807 ISRAEL VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 808 ISRAEL VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 809 ISRAEL SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 810 ISRAEL LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 811 ISRAEL INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 812 ISRAEL TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 813 ISRAEL VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 814 ISRAEL ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 815 ISRAEL RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 816 ISRAEL REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 817 ISRAEL VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 818 ISRAEL PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 819 ISRAEL ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 820 ISRAEL VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 821 ISRAEL VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 822 ISRAEL INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 823 ISRAEL VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 824 ISRAEL VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 825 KUWAIT VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 826 KUWAIT VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 827 KUWAIT SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 828 KUWAIT LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 829 KUWAIT INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 830 KUWAIT TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 831 KUWAIT VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 832 KUWAIT ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 833 KUWAIT RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 834 KUWAIT REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 835 KUWAIT VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 836 KUWAIT PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 837 KUWAIT ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 838 KUWAIT VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 839 KUWAIT VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 840 KUWAIT INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 841 KUWAIT VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 842 KUWAIT VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 843 EGYPT VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 844 EGYPT VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 845 EGYPT SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 846 EGYPT LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 847 EGYPT INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 848 EGYPT TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 849 EGYPT VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 850 EGYPT ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 851 EGYPT RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 852 EGYPT REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 853 EGYPT VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 854 EGYPT PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 855 EGYPT ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 856 EGYPT VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 857 EGYPT VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 858 EGYPT INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 859 EGYPT VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 860 EGYPT VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 861 REST OF MIDDLE EAST & AFRICA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 862 SOUTH AMERICA VACCINES MARKET, BY COUNTRY, 2018-2028 (USD MILLION)

TABLE 863 SOUTH AMERICA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 864 SOUTH AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 865 SOUTH AMERICA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 866 SOUTH AMERICA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 867 SOUTH AMERICA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 868 SOUTH AMERICA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 869 SOUTH AMERICA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 870 SOUTH AMERICA ROUTINE VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 871 SOUTH AMERICA RECOMMENDED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 872 SOUTH AMERICA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 873 SOUTH AMERICA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 874 SOUTH AMERICA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 875 SOUTH AMERICA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 876 SOUTH AMERICA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 877 SOUTH AMERICA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 878 SOUTH AMERICA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 879 SOUTH AMERICA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 880 SOUTH AMERICA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 881 BRAZIL VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 882 BRAZIL VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 883 BRAZIL SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 884 BRAZIL LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 885 BRAZIL INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 886 BRAZIL TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 887 BRAZIL VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 888 BRAZIL ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 889 BRAZIL RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 890 BRAZIL REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 891 BRAZIL VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 892 BRAZIL PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 893 BRAZIL ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 894 BRAZIL VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 895 BRAZIL VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 896 BRAZIL INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 897 BRAZIL VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 898 BRAZIL VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 899 ARGENTINA VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 900 ARGENTINA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 901 ARGENTINA SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 902 ARGENTINA LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 903 ARGENTINA INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 904 ARGENTINA TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 905 ARGENTINA VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 906 ARGENTINA ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 907 ARGENTINA RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 908 ARGENTINA REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 909 ARGENTINA VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 910 ARGENTINA PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 911 ARGENTINA ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 912 ARGENTINA VACCINES MARKET, BY DISEASE, 2019-2028 (USD MILLION)

TABLE 913 ARGENTINA VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 914 ARGENTINA INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 915 ARGENTINA VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 916 ARGENTINA VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 917 PERU VACCINES MARKET, BY COMPOSITION, 2019-2028 (USD MILLION)

TABLE 918 PERU VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 919 PERU SUBUNIT, RECOMBINANT, POLYSACCHARIDE & CONJUGATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 920 PERU LIVE-ATTENUATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 921 PERU INACTIVATED VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 922 PERU TOXOID VACCINES IN VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

TABLE 923 PERU VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 924 PERU ROUTINE VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 925 PERU RECOMMENDED VACCINES IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 926 PERU REQUIRED VACCINE IN VACCINES MARKET, BY KIND, 2019-2028 (USD MILLION)

TABLE 927 PERU VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 928 PERU PEDIATRIC VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 929 PERU ADULT VACCINE IN VACCINES MARKET, BY AGE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 930 PERU VACCINES MARKET, BY DISEASES, 2019-2028 (USD MILLION)

TABLE 931 PERU VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 932 PERU INJECTABLE IN VACCINES MARKET, BY ROUTE OF ADMINISTRATION, 2019-2028 (USD MILLION)

TABLE 933 PERU VACCINES MARKET, BY END USER, 2019-2028 (USD MILLION)

TABLE 934 PERU VACCINES MARKET, BY DISTRIBUTION CHANNEL, 2019-2028 (USD MILLION)

TABLE 935 REST OF SOUTH AMERICA VACCINES MARKET, BY TYPE, 2019-2028 (USD MILLION)

 

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Browse Related Reports

Global Companion Animal Vaccines Market - Industry Trends and Forecast to 2028

Global Veterinary-Animal Vaccines Market – Industry Trends and Forecast to 2028

Global Deoxyribonucleic Acid (DNA) Vaccines Market – Industry Trends and Forecast to 2028

Global Personalized Cancer Vaccines Market - Industry Trends and Forecast to 2028

Global Conjugate Vaccines Market – Industry Trends and Forecast to 2028

Global Toxoid Vaccines Market – Industry Trends and Forecast to 2028

Global Live Attenuated Vaccines Market - Industry Trends and Forecast to 2028

Global Porcine Vaccines Market - Industry Trends and Forecast to 2027

Global Inactivated Vaccines Market – Industry Trends and Forecast to 2027

Global Malaria Vaccines Market - Industry Trends and Forecast to 2027

Global Bacterial Vaccines Market - Industry Trends and Forecast to 2027

Global Preventable Vaccines Market - Industry Trends and Forecast to 2027

Global Flu Vaccines Market – Industry Trends and Forecast to 2027

Global Avian Influenza Vaccines Market – Industry Trends and Forecast to 2027

Global Cholera Vaccines Market - Industry Trends and Forecast to 2027

Global Meningococcal Vaccines Market - Industry Trends and Forecast to 2027

Global Human Rabies Vaccines Market - Industry Trends and Forecast to 2027

Global Poultry Vaccines Market - Industry Trends and Forecast to 2028

Global Human Combination Vaccines Market - Trends and Forecast to 2028

Asia-Pacific Vaccines Market – Industry Trends and Forecast to 2028

Europe Vaccines Market – Industry Trends and Forecast to 2028

North America Vaccines Market – Industry Trends and Forecast to 2028

Middle East and Africa Vaccines Market – Industry Trends and Forecast to 2028

Global Measles, Mumps and Rubella Vaccines Market – Industry Trends and Forecast to 2028

Global Bovine Ephemeral Fever Vaccines Market – Industry Trends and Forecast to 2028

Global Therapeutic Proteins and Oral Vaccines Market - Industry Trends and Forecast to 2028